MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0059755
Maple Cross Remedies Private Limited
Maple Cross Remedies Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.57 Cr
▼ 5% YoY
Net profit · FY 2024
₹77.5 Lakh
Net margin 2.6%
EBITDA · FY 2024
₹1.18 Cr
EBITDA margin 4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.01 Lakh
Issued & subscribed
Open charges
₹1.57 Cr
Satisfied ₹3.26 Cr
Company age
25 yrs
Est. 2001
Directors on board
6
As per MCA filings
About Maple Cross Remedies Private Limited
Data last updated:
Maple Cross Remedies Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 June 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85199MH2001PTC132312. Its GSTIN is 27AABCD3408R1ZD (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.01 Lakh. It is led by directors including Jaikishan Mangharam Shahani and Mahesh Rochaldas Bakhru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.57 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹77.5 Lakh (net margin 2.6%) and EBITDA of ₹1.18 Cr (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 17% over five years.
As per MCA filings, the company has open charges of ₹1.57 Cr and satisfied charges of ₹3.26 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
Maple Cross Remedies Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0059755). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85199MH2001PTC132312
Registration Number 132312
Incorporation Date 12 June 2001
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0059755
Key People
Jaikishan Mangharam Shahani Director Mahesh Rochaldas Bakhru Director Anuj Jaikishen Shahani Director Recognitions & Rankings of Maple Cross Remedies
Contact details
Maple Cross Remedies Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 714 Autumn Grove Chs Ltd. Akurli Road Near Lokhandwala Foundation School Kand, Ivali (E), Mumbai, Maharashtra, India – 400101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maple Cross Remedies Private Limited, buy the company report.
Comprehensive company report
Maple Cross Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maple Cross Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maple Cross Remedies Private Limited, buy the company report.
Financials of Maple Cross Remedies Private Limited
FY 2025 filings availableMaple Cross Remedies Private Limited reported revenue of ₹29.57 Cr (down 5% YoY) for FY 2024.
Revenue · FY 2024
₹29.57 Cr ▼ 5%
Net profit · FY 2024
₹77.5 Lakh margin 2.6%
EBITDA · FY 2024
₹1.18 Cr margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 11%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 10%
5 years · compounded
▲ 4%
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maple Cross Remedies Private Limited, buy the company report.
Board of directors of Maple Cross Remedies Private Limited
Maple Cross Remedies has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaikishan Mangharam Shahani Also directs: Liricon Trading Private Limited | Director | 12 Jun 2001 | 25 Years 4 Months | Current |
| Mahesh Rochaldas Bakhru Also directs: Mapcon Meditech Private Limited, Liricon Trading Private Limited | Director | 12 Jun 2001 | 25 Years 4 Months | Current |
| Anuj Jaikishen Shahani Also directs: Mapcon Meditech Private Limited, Liricon Trading Private Limited | Director | 16 Aug 2005 | 21 Years 2 Months | Current |
| Usha Shahani Also directs: Liricon Trading Private Limited | Director | 26 May 2015 | 11 Years 5 Months | Current |
| Deepika Shahani Also directs: Liricon Trading Private Limited | Director | 26 May 2015 | 11 Years 5 Months | Current |
| Roma Mahesh Bakhru Also directs: Liricon Trading Private Limited | Director | 26 May 2015 | 11 Years 5 Months | Current |
Peer comparison
Maple Cross Remedies Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vrnda Pharma Private Limited | ₹29.73 Cr (FY 2025) | 164.0% | Mumbai, Maharashtra, India | |||
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Infugen Pharma Private Limited | ₹29.66 Cr (FY 2025) | -21.0% | Sangli, Maharashtra, India | |||
| Growmax Medicare Private Limited | ₹29.58 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Maple Cross Remedies Private Limitedthis company | ₹29.57 Cr (FY 2024) | ₹77.5 Lakh | 2.6% | -5.0% | Mumbai, Maharashtra, India | |
| Madhya Pradesh Public Health Services Corporation Limited | ₹29.27 Cr (FY 2023) | -5.0% | Bhopal, Madhya Pradesh, India | |||
| Dellarex Biotec Private Limited | ₹29.19 Cr (FY 2025) | 34.0% | Thane, Maharashtra, India |
To see the full peer comparison of Maple Cross Remedies Private Limited, buy the company report.
Auditor
Maple Cross Remedies Private Limited is audited by H F VORA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H F VORA & CO | FY 2023 | 114334W |
Shareholding
The shareholding of Maple Cross Remedies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maple Cross Remedies Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.57 Cr
Satisfied charges
₹3.26 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Mar 2024 | 100892934 | Hdfc Bank Limited | ₹25.79 Lakh | Open | |
| 03 Mar 2022 | 100552411 | Hdfc Bank Limited | ₹15 Lakh | Open | |
| 30 Jun 2021 | 100455564 | Others | ₹1.01 Cr | Open | |
| 12 Jan 2005 | 90158544 | Corporation Bank | ₹15 Lakh | Open | |
| 12 May 2021 | 100445465 | Others | ₹2.7 Cr | Satisfied |
To see the full charge records of Maple Cross Remedies Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Maple Cross Remedies Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed against the company by individuals | Disposed |
To see the full case history of Maple Cross Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maple Cross Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maple Cross Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCD3408R1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maple Cross Remedies Private Limited, buy the company report.
Recent activity
Maple Cross Remedies Private Limited has 11 board changes on record since 2001: 6 appointments and 5 cessations. The latest: Anuj Jaikishen Shahani ceased to be Director on 02 Mar 2022.
AGM
Maple Cross Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Maple Cross Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.79 Lakh with Charge ID 100892934 was registered on 02 Mar 2024.
Charges
A charge registered on 24 May 2017 via Charge ID 100127537 with Hdfc Bank Limited was fully satisfied on 25 Jul 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 100552411 was registered on 03 Mar 2022.
Ceased
Anuj Jaikishen Shahani ceased to be Director.
Ceased
Deepika Shahani ceased to be Director.
Ceased
Jaikishan Mangharam Shahani ceased to be Director.
Ceased
Roma Mahesh Bakhru ceased to be Director.
Ceased
Usha Shahani ceased to be Director.
Charges
A charge registered on 12 May 2021 via Charge ID 100445465 with Others was fully satisfied on 24 Sep 2021.
Charges
A charge with Others amounted to Rs. 101.00 Lakh with Charge ID 100455564 was registered on 30 Jun 2021.
10 earlier events are in the company report.
Frequently asked questions
Maple Cross Remedies is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 June 2001 (25+ years old) and is registered under CIN U85199MH2001PTC132312.
Maple Cross Remedies has 6 current directors:
- Jaikishan Mangharam Shahani - Director
- Mahesh Rochaldas Bakhru - Director
- Anuj Jaikishen Shahani - Director
- Usha Shahani - Director
- Deepika Shahani - Director
- Roma Mahesh Bakhru - Director
The latest financial statements of Maple Cross Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maple Cross Remedies is 27AABCD3408R1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maple Cross Remedies is U85199MH2001PTC132312. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maple Cross Remedies has 2 court cases on record: 2 filed against it.
Maple Cross Remedies was incorporated on 12 June 2001, making it 25+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Maple Cross Remedies by revenue are Vrnda Pharma Private Limited, Cedric Pharmaceuticals Private Limited, Infugen Pharma Private Limited, Growmax Medicare Private Limited, Madhya Pradesh Public Health Services Corporation Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anuj Jaikishen Shahani ceased to be Director on 02 Mar 2022. Deepika Shahani ceased to be Director on 02 Mar 2022. Jaikishan Mangharam Shahani ceased to be Director on 02 Mar 2022. Maple Cross Remedies has 11 board changes on record in total.
Yes, Maple Cross Remedies is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0059755).
The registered office of Maple Cross Remedies is at F – 714 Autumn Grove Chs Ltd. Akurli Road Near Lokhandwala Foundation School Kand, Ivali E, Mumbai, Maharashtra, India – 400101.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages